Axogen Inc (AXGN) Stock Price, Quote & News

Company Profile

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wra...

Industry: Medical Devices

Sector: Healthcare

Phone: 386 462 6800

Fax: 386 462 6801

Website: www.axogeninc.com

Address:

13631 Progress Boulevard, Suite 400, Alachua, United States

dustin1101 Jul. 21 at 2:26 PM

Looking more like the $AXGN I know. Sell algo is turned off. Could be back in the 42s quickly.

0 · Reply

newsofthemarket Jul. 20 at 11:51 AM

$AXGN Something is up with this name Takeover possible! Looking like a prime medical biotech buyout bait $103.6M in cash/investments & 100% DEBT-FREE after clearing their Oberland facility Revs growing 26.6% YoY to $61.5M with 75% gross margins Major CMS & Cigna reimbursement tailwinds driving nerve graft adoption FI's own 91% + 12% more added Bessemer just increased their position by 41%. With a $2.1B market cap, a larger player like Stryker or J&J could easily pay a premium to grab this specialized biological moat. Eyes on a potential $60-80$+ takeout valuation. https://www.marketbeat.com/instant-alerts/filing-axogen-inc-axgn-shares-acquired-by-bessemer-group-inc-2026-07-19/

0 · Reply

dustin1101 Jul. 17 at 2:07 PM

$AXGN should go green.. XBI is rippin back up.

0 · Reply

alphatrades09 Jul. 16 at 2:35 PM

$AXGN These contracts are exploding don’t miss it

0 · Reply

ApexEquityVault Jul. 16 at 2:33 PM

Potential 5x can go insane✌️ $AXGN 55 Call 8/21 at 0.55

0 · Reply

alphatrades09 Jul. 16 at 2:33 PM

$AXGN 55C 8/21 — 0.00

0 · Reply

ApexEquityVault Jul. 16 at 2:33 PM

$AXGN 55 Call 8/21 at 0.55

0 · Reply

dustin1101 Jul. 15 at 3:28 PM

$AXGN starting to see perhaps a hint of sector rotation tailwind. Still an active seller here. I'm betting they are taken out soon. Possible bottom forming. We'll see.

0 · Reply

dustin1101 Jul. 15 at 12:42 PM

$AXGN ER July 29 pre-mkt, CC 8am ET. https://www.globenewswire.com/news-release/2026/07/15/3327571/0/en/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-29-2026.html

0 · Reply

dustin1101 Jul. 14 at 1:50 PM

$AXGN mkt green but we're down here under 39, got some 38.40. Great entry point. Low volume. Who flinches first?

0 · Reply

Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down

STIM

Jul 15, 2026, 7:00 AM EDT - 6 days ago

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

Jun 23, 2026, 8:30 AM EDT - 4 weeks ago

Axogen Transcript: AGM 2026

May 13, 2026, 12:35 PM EDT - 2 months ago

Axogen Transcript: Bank of America Global Healthcare Conference 2026

Apr 30, 2026, 7:00 AM EDT - 2 months ago

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

2026-04-29T16:57:39.000Z - 2 months ago

AxoGen price target raised to $48 from $41 at Raymond James

2026-04-29T13:02:40.000Z - 2 months ago

AxoGen price target raised to $50 from $45 at Canaccord

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Axogen Proxy statement: Proxy filing

2026-04-29T10:16:26.000Z - 2 months ago

AxoGen price target raised to $50 from $39 at H.C. Wainwright

2026-04-29T09:53:29.000Z - 2 months ago

AxoGen price target raised to $50 from $42 at Citizens

2026-04-28T14:28:46.000Z - 3 months ago

AxoGen rises 12.8%

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Axogen Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Axogen Earnings release: Q1 2026

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Axogen Slides: Q1 2026

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Axogen Quarterly report: Q1 2026

2026-04-28T11:49:44.000Z - 3 months ago

AxoGen raises FY26 revenue view to $270M from $265.7M, consensus $265.89M

2026-04-28T11:08:24.000Z - 3 months ago

AxoGen reports Q1 adjusted EPS 7c, consensus 7c

Apr 28, 2026, 7:00 AM EDT - 3 months ago

Axogen, Inc. Reports First Quarter 2026 Financial Results

2026-04-24T11:16:41.000Z - 3 months ago

AxoGen price target raised to $45 from $40 at Canaccord

2026-04-23T12:44:20.000Z - 3 months ago

AxoGen price target raised to $50 from $40 at Lake Street

2026-04-16T20:00:22.000Z - 3 months ago

AxoGen jumps after Cigna picks up Avance nerve graft

Apr 14, 2026, 7:00 AM EDT - 3 months ago

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Mar 10, 2026, 12:30 PM EDT - 4 months ago

Axogen Transcript: The Citizens Life Sciences Conference 2026

Mar 9, 2026, 1:00 PM EDT - 4 months ago

Axogen Transcript: Leerink Global Healthcare Conference 2026

Mar 4, 2026, 6:00 AM EST - 4 months ago

Axogen Slides: Corporate presentation

Mar 3, 2026, 3:25 PM EST - 4 months ago

Axogen Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 24, 2026, 8:00 AM EST - 5 months ago

Axogen Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Axogen Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Axogen Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Axogen Slides: Q4 2025

2026-02-24T12:06:53.000Z - 5 months ago

AxoGen reports Q4 adjusted EPS 7c, consensus 10c

2026-02-24T12:05:30.000Z - 5 months ago

AxoGen sees FY26 revenue $265.7M, consensus $259.53M

2026-02-24T10:40:34.000Z - 5 months ago

AxoGen price target raised to $42 from $34 at Citizens

2026-02-23T14:45:11.000Z - 5 months ago

AxoGen price target raised to $41 from $36 at Raymond James

2026-02-19T10:55:34.000Z - 5 months ago

AxoGen initiated with an Overweight at Wells Fargo

Feb 17, 2026, 7:00 AM EST - 5 months ago

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Feb 10, 2026, 7:00 AM EST - 5 months ago

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

2026-01-22T13:46:34.000Z - 6 months ago

AxoGen 4M share Spot Secondary priced at $31.00

Jan 21, 2026, 11:18 PM EST - 6 months ago

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

2026-01-21T21:16:01.000Z - 6 months ago

AxoGen announces $85M common stock offering

Jan 21, 2026, 4:09 PM EST - 6 months ago

Axogen Announces Proposed Public Offering of Common Stock

2026-01-21T21:05:26.000Z - 6 months ago

AxoGen files automatic mixed securities shelf

Jan 15, 2026, 1:30 PM EST - 6 months ago

Axogen Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 1:30 PM EST - 6 months ago

Axogen Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 6 months ago

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Dec 3, 2025, 8:01 PM EST - 8 months ago

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

Dec 3, 2025, 6:53 PM EST - 8 months ago

FDA approves Axogen's nerve repair graft

Dec 2, 2025, 12:30 PM EST - 8 months ago

Axogen Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 11:30 AM EST - 8 months ago

Axogen Transcript: Jefferies London Healthcare Conference 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Axogen Earnings Call Transcript: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Axogen Quarterly report: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Axogen Earnings release: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Axogen Slides: Q3 2025

Oct 29, 2025, 7:00 AM EDT - 9 months ago

Axogen, Inc. Reports Third Quarter 2025 Financial Results

Oct 1, 2025, 12:30 PM EDT - 10 months ago

Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN

Aug 25, 2025, 6:40 AM EDT - 11 months ago

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Axogen Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Axogen Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Axogen Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Axogen Slides: Q2 2025

Jul 29, 2025, 4:10 PM EDT - 1 year ago

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

Jul 22, 2025, 4:05 PM EDT - 1 year ago

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Axogen Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 1 year ago

Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference

May 8, 2025, 8:00 AM EDT - 1 year ago

Axogen Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Axogen Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Axogen Earnings release: Q1 2025

May 8, 2025, 7:05 AM EDT - 1 year ago

Axogen, Inc. Reports 2025 First Quarter Financial Results

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Axogen Proxy statement: Proxy Filing

Apr 24, 2025, 8:04 AM EDT - 1 year ago

Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025

Mar 4, 2025, 9:00 AM EST - 1 year ago

Axogen Transcript: Investor Day 2025

Mar 4, 2025, 9:00 AM EST - 1 year ago

Axogen Slides: FY 2025

Feb 25, 2025, 8:00 AM EST - 1 year ago

Axogen Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Axogen Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Axogen Earnings release: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Axogen Slides: Q4 2024

Feb 25, 2025, 7:10 AM EST - 1 year ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 11, 2025, 4:58 PM EST - 1 year ago

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

Jan 10, 2025, 5:00 PM EST - 1 year ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 7, 2024, 8:00 AM EST - 1 year ago

Axogen Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Axogen Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Axogen Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Axogen Slides: Q3 2024

Sep 6, 2024, 7:00 AM EDT - 2 years ago

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Axogen Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Axogen Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Axogen Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Axogen Slides: Q2 2024

Aug 8, 2024, 7:05 AM EDT - 2 years ago

Axogen, Inc. Announces New Leadership Appointments

Jul 23, 2024, 7:00 AM EDT - 2 years ago

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Jul 1, 2024, 7:00 AM EDT - 2 years ago

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

Jun 24, 2024, 7:00 AM EDT - 2 years ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

May 29, 2024, 4:40 PM EDT - 2 years ago

Axogen Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

May 28, 2024, 4:30 PM EDT - 2 years ago

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

May 2, 2024, 8:00 AM EDT - 2 years ago

Axogen Earnings Call Transcript: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Axogen Quarterly report: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Axogen Earnings release: Q1 2024

May 2, 2024, 7:00 AM EDT - 2 years ago

Axogen, Inc Reports First Quarter 2024 Financial Results

Apr 29, 2024, 4:50 PM EDT - 2 years ago

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Apr 24, 2024, 8:00 AM EDT - 2 years ago

Axogen Proxy statement: Proxy Filing

Apr 16, 2024, 7:00 AM EDT - 2 years ago

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

Axogen Proxy statement: Proxy Filing

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Axogen Registration statement: Registration Filing

Mar 6, 2024, 7:00 AM EST - 2 years ago

Axogen Registration statement: Registration Filing

Mar 5, 2024, 8:00 AM EST - 2 years ago

Axogen Earnings Call Transcript: Q4 2023

Mar 5, 2024, 8:00 AM EST - 2 years ago

Axogen Annual report: Q4 2023

Mar 5, 2024, 8:00 AM EST - 2 years ago

Axogen Earnings release: Q4 2023

Mar 5, 2024, 7:00 AM EST - 2 years ago

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

Feb 13, 2024, 4:30 PM EST - 2 years ago

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

Feb 2, 2024, 4:15 PM EST - 2 years ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Jan 18, 2024, 5:00 PM EST - 2 years ago

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

Jan 4, 2024, 4:45 PM EST - 2 years ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

Jan 4, 2024, 4:40 PM EST - 2 years ago

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

Jan 4, 2024, 4:35 PM EST - 2 years ago

Axogen Announces Promotions on Research and Development Team

Dec 26, 2023, 4:15 PM EST - 2 years ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 6, 2023, 7:00 AM EST - 2 years ago

Axogen Announces Transition of Finance Team Leadership

Dec 1, 2023, 5:00 PM EST - 2 years ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 30, 2023, 8:50 AM EST - 2 years ago

Axogen Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 7, 2023, 8:00 AM EST - 2 years ago

Axogen Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Axogen Quarterly report: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Axogen Earnings release: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Axogen Slides: Q3 2023

Nov 7, 2023, 7:00 AM EST - 2 years ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results

Oct 18, 2023, 7:00 AM EDT - 2 years ago

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

Sep 5, 2023, 7:00 AM EDT - 3 years ago

Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™

Aug 31, 2023, 7:00 AM EDT - 3 years ago

Axogen to Participate at Upcoming Investor Conferences

Aug 21, 2023, 7:00 AM EDT - 3 years ago

Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio

Aug 7, 2023, 4:30 PM EDT - 3 years ago

Axogen Earnings Call Transcript: Q2 2023

Aug 7, 2023, 4:30 PM EDT - 3 years ago

Axogen Quarterly report: Q2 2023

Aug 7, 2023, 4:30 PM EDT - 3 years ago

Axogen Earnings release: Q2 2023

Aug 7, 2023, 4:30 PM EDT - 3 years ago

Axogen Slides: Q2 2023

Aug 7, 2023, 4:01 PM EDT - 3 years ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results

dustin1101 Jul. 21 at 2:26 PM

Looking more like the $AXGN I know. Sell algo is turned off. Could be back in the 42s quickly.

0 · Reply

newsofthemarket Jul. 20 at 11:51 AM

0 · Reply

dustin1101 Jul. 17 at 2:07 PM

$AXGN should go green.. XBI is rippin back up.

0 · Reply

alphatrades09 Jul. 16 at 2:35 PM

$AXGN These contracts are exploding don’t miss it

0 · Reply

ApexEquityVault Jul. 16 at 2:33 PM

Potential 5x can go insane✌️ $AXGN 55 Call 8/21 at 0.55

0 · Reply

alphatrades09 Jul. 16 at 2:33 PM

$AXGN 55C 8/21 — 0.00

0 · Reply

ApexEquityVault Jul. 16 at 2:33 PM

$AXGN 55 Call 8/21 at 0.55

0 · Reply

dustin1101 Jul. 15 at 3:28 PM

$AXGN starting to see perhaps a hint of sector rotation tailwind. Still an active seller here. I'm betting they are taken out soon. Possible bottom forming. We'll see.

0 · Reply

dustin1101 Jul. 15 at 12:42 PM

$AXGN ER July 29 pre-mkt, CC 8am ET. https://www.globenewswire.com/news-release/2026/07/15/3327571/0/en/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-29-2026.html

0 · Reply

dustin1101 Jul. 14 at 1:50 PM

$AXGN mkt green but we're down here under 39, got some 38.40. Great entry point. Low volume. Who flinches first?

0 · Reply

Tekoa Jul. 14 at 1:18 PM

$AXGN Found something this morning that could explain some of the recent lower movement, amongst other factors. Axogen was removed from the Russell Microcap Index and the Russell 3000E indexes because its market capitalization fell below the required thresholds during the annual reconstitution." The removal date was June 26. This is the article published Jul 9: https://www.sahmcapital.com/news/content/axogen-axgn-as-russell-index-removal-tests-a-narrative-of-undervaluation-2026-07-10

1 · Reply

dustin1101 Jul. 13 at 4:26 PM

$AXGN just going to take some patience to get out of the doldrums of these crappy market days. Nobody wants to buy now but when it starts trending upward and/or a catalyst hits, game on. Will keep adding small pieces on dips. GLTA.

0 · Reply

TheMarketsTheTarget Jul. 11 at 12:43 AM

$AXGN Got some 40.75

0 · Reply

Tekoa Jul. 10 at 7:24 PM

$AXGN Analyst — Firm Rating Price Target Date Jefferies — Sarcone Buy $50 Jul 6 2026 Canaccord — Roberts Buy $50 May 4 2026 Mizuho — Petrone Buy $55 Apr 30 2026 Raymond James — Bedford Buy $48 Apr 29 2026 Wells Fargo — Biegelsen Buy $48 Apr 29 2026 Citizens JMP Market Outperform $50 Apr 29 2026 Citigroup Outperform N/A Apr 29 2026 HC Wainwright — Yi Chen Buy $50 Apr 29 2026 Wall Street Zen Buy N/A Jul 4 2026 Zacks Hold N/A May 29 2026 Weiss Ratings Sell N/A May 29 2026F

0 · Reply

TheMarketsTheTarget Jul. 10 at 2:15 PM

$AXGN Shit Bomb Style

2 · Reply

dustin1101 Jul. 10 at 2:06 PM

$AXGN going awfully deep into the book here on the sector dip while we hardly participated in its rally.. sniping some cheap ones here.

0 · Reply

dustin1101 Jul. 9 at 3:03 PM

$AXGN holding up well. Probably just a few more dum-dums willing to sell these levels and then march back to 46.

0 · Reply

TheMarketsTheTarget Jul. 9 at 7:02 AM

$AXGN Will grab some today if stays here or lower

0 · Reply

dustin1101 Jul. 8 at 7:49 PM

$AXGN loading 300 more here.

0 · Reply

dustin1101 Jul. 8 at 1:43 PM

$AXGN Bidding here.

0 · Reply

dustin1101 Jul. 7 at 1:50 PM

$AXGN you can set your clock to this action at this point. Snagging some low 45s to start.

0 · Reply

TheMarketsTheTarget Jul. 7 at 11:19 AM

$AXGN AI trade showing holes Here is going to come some action.

0 · Reply

Market Cap	2.12B
Revenue (ttm)	225.21M
Net Income (ttm)	-15.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.97%
Debt to Equity Ratio	0.01

Volume	1,063,900
Avg Vol	1,240,074
Day's Range	N/A - N/A
Shares Out	53.18M
Stochastic %K	21%
Beta	1.09
Analysts	Strong Sell
Price Target	$50.22